Search results for "Glycaemic Control"
showing 3 items of 13 documents
DETERMINATION OF MAXIMAL FAT OXIDATION FOR PRESCRIBING EXERCISE IN SEDENTARY NON-OBESE TYPE 2 DIABETES SUBJECTS
2014
Aim: To determine the exercise intensity that elicits the highest fat oxidation rate in sedentary non-obese subjects with type 2 diabetes. Methods: Eleven sedentary subjects with type 2 diabetes (T2DS) and eleven healthy sedentary subjects (HS), aged 45 to 65 and non-obese, were evaluated to a graded exercise test. Oxygen uptake (VO2) and fat oxidation rate (FAT) were detected. FAT was then plotted as a function of exercise intensity, expressed as percentage of VO2max. We determined the exercise intensity (%VO2max) at which fat oxidation was maximal (FATmax). Results: Absolute FATmax was not significantly different between T2DS and HS (0.51 0.13 vs. 0.56 0.29 g∙min-1). FATmax occurred a…
Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐…
2020
Abstract Aim To assess the impact of the timing of initiating both basal insulin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on reaching glycaemic control targets over 6 and 12 months in people with type 2 diabetes (T2D) uncontrolled on oral antihyperglycaemic drugs with an HbA1c of 9% or higher. Methods This retrospective cohort study assessed the impact of the timing of initiating both basal insulin and GLP‐1 RA therapies on reaching glycaemic targets (HbA1c < 7% and <8%, and ≥1% and ≥2% HbA1c reduction) over 12 months in people with markedly uncontrolled T2D (HbA1c ≥ 9%) on oral antihyperglycaemic drugs identified on the Optum Humedica database (electronic medical records; …
Associations between type of treatment and illness-specific locus of control in type 1 diabetes patients
1993
Abstract This study examined differences in diabetes-specific locus of control beliefs of 82 insulin-treated Type I diabetes patients undergoing either conventional therapy (CT), intensified conventional therapy (ICT) or continuous subcutaneous insulin infusion (CSII). Compared to CT with its adherence to a strict regimen, ICT and CSII allow a much greater flexibility in timing of meals and daily activities. On the other hand, such flexibility requires a much more active role of the patient. The hypotheses of higher internality and lower powerful others locus of control beliefs in ICT and CSII patients than in CT patients could be supported for powerful others locus of control only. A one-y…